２０２３年
- Metabolic changes in the plasma of mild Alzheimer's disease patients treated with Hachimijiogan.
- Kainuma M, Kawakatsu S, Kim JD, Ouma S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y.
Front Pharmacol. 2023 Jun 12;14:1203349. doi:10.3389/fphar.2023.1203349.
- CGG repeat expansion in LRP12 in amyotrophic lateral sclerosis.
- Kume K, Kurashige T, Muguruma K, Morino H, Tada Y, Kikumoto M, Miyamoto T, Akutsu SN, Matsuda Y, Matsuura S, Nakamori M, Nishiyama A, Izumi R, Niihori T, Ogasawara M, Eura N, Kato T, Yokomura M, Nakayama Y, Ito H, Nakamura M, Saito K, Riku Y, Iwasaki Y, Maruyama H, Aoki Y, Nishino I, Izumi Y, Aoki M, Kawakami H.
Am J Hum Genet. 2023 Jul 6;110(7):1086-1097. doi: 10.1016/j.ajhg.2023.05.014.
- Drugs Used to Treat Essential Tremors.
- Miyamoto K, Ito H.
Brain Nerve. 2023 May;75(5):549-552. Japanese. doi: 10.11477/mf.1416202376.
- Varicella-zoster virus infection with concomitant lower cranial polyneuropathy in the absence of fever, headache and meningeal signs.
- Murakami K, Kanzaki K, Kajimoto Y, Ito H.
Rinsho Shinkeigaku. 2023 Apr 25;63(4):225-230. Japanese. doi:10.5692/clinicalneurol.cn-001818.
- Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders.
- Miyamoto K, Minamino M, Kuwahara M, Tsujimoto H, Ohtani K, Wakamiya N, Katayama KI, Inoue N, Ito H.
Front Immunol. 2023 Mar 3;14:1090548. doi: 10.3389/fimmu.2023.1090548.
- Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes.
- Murakami K, Sakamoto K, Ishiguchi H, Ito H.
J Stroke Cerebrovasc Dis. 2023 May;32(5):107080. doi:10.1016/j.jstrokecerebrovasdis.2023.107080.
- Recent changes in the frequency of use of apheresis and biological drugs in the treatment of neuromyelitis optica spectrum disorders.
- Miyamoto K, Nakayama Y, Ito H.
Ther Apher Dial. 2023 Aug;27(4):819-820. doi: 10.1111/1744-9987.13977.
- Involvement of heterologous ubiquitination including linear ubiquitination in Alzheimer's disease and amyotrophic lateral sclerosis.
- Sato Y, Terawaki S, Oikawa D, Shimizu K, Okina Y, Ito H, Tokunaga F.
Front Mol Biosci. 2023 Jan 16;10:1089213. doi: 10.3389/fmolb.2023.1089213.
- Neuropathology of spinocerebellar ataxia type 8: Common features and unique tauopathy.
- Yonenobu Y, Beck G, Kido K, Maeda N, Yamashita R, Inoue K, Saito Y, Hasegawa M, Ito H, Hasegawa K, Morii E, Iwaki T, Murayama S, Mochizuki H.
Neuropathology. 2023 Jan 26. doi: 10.1111/neup.12894.
- Identification of double-stranded DNA in the cerebrospinal fluid of patients with acute neuromyelitis optica spectrum disorder.
- Yamamoto M, Okuno T, Piao JL, Shimizu M, Miyamoto K, Nukui T, Kinoshita M, Koda T, Dini Haryuni R, Mochizuki H, Sugimoto T, Nakatsuji Y.
J Clin Neurosci. 2023 Jan:107:129-132. doi: 10.1016/j.jocn.2022.12.005.
- Diagnostic utility of susceptibility-weighted imaging in amyotrophic
lateral sclerosis
- Yasui M, Koh J, Nakayama Y, Sakata M, Hiwatani Y, Ishiguchi H, Ito H.
J Neurol Sci. 2023 Jan 15:444:120524. doi: 10.1016/j.jns.2022.120524.
- Real-world application of plasmapheresis for neurological disease: Results from the Japan-Plasmapheresis Outcome and Practice Patterns Study.
- Lin Y, Oji S, Miyamoto K, Narita T, Kameyama M, Matsuo H.
Ther Apher Dial. 2023 Feb;27(1):123-135. doi: 10.1111/1744-9987.13906.
- Characteristics of Guillain-Barré syndrome in super-elderly individuals.
- Minamino M, Miyamoto K, Kuwahara M, Yoshikawa K, Koh J, Kusunoki S, Nagai Y, Ito H.
J Neurol. 2023 Apr;270(4):2191-2196. doi: 10.1007/s00415-023-11567-8.
- Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder.
- Matsuoka T, Araki M, Lin Y, Okamoto T, Gold R, Chihara N, Sato W, Kimura A, Tachimori H, Miyamoto K, Kusunoki S, Yamamura T.
Neurol Neuroimmunol Neuroinflamm. 2023 Oct 20;11(1):e200173. doi: 10.1212/NXI.0000000000200173.
- Predictive value of the neutrophil-to-lymphocyte ratio for treatment response in patients diagnosed with definite or probable autoimmune encephalitis/encephalopathy.
- Ogami S, Koh J, Miyamoto K, Mori M, Takahashi M, Nakayama Y, Sakata M, Hiwatani Y, Kajimoto Y, Ishiguchi H, Ito H.
Front Neurol. 2023 Oct 23:14:1284717. doi: 10.3389/fneur.2023.1284717.
PAGE TOP
